ViraCyte's Series A Round

ViraCyte raised a round of funding on October 02, 2018. Investors include MPM Capital.

ViraCyte is a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe life-threatening infections. The company provides products that restore…

Articles about ViraCyte's Series A Round: